These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 12375267

  • 1. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A, Krassort M, Buchwalow IB, Végh A, Felszeghy E, Piffkó J.
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [Abstract] [Full Text] [Related]

  • 3. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
    Bagutti C, Speight PM, Watt FM.
    J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
    [Abstract] [Full Text] [Related]

  • 4. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO.
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [Abstract] [Full Text] [Related]

  • 5. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
    Ashida K, Terada T, Kitamura Y, Kaibara N.
    Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU.
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [Abstract] [Full Text] [Related]

  • 8. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M, Lee HK, Kang YK.
    Anticancer Res; 2003 Jan; 23(2B):1581-8. PubMed ID: 12820426
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K.
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [Abstract] [Full Text] [Related]

  • 12. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
    Mikami T, Saegusa M, Mitomi H, Yanagisawa N, Ichinoe M, Okayasu I.
    Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
    [Abstract] [Full Text] [Related]

  • 13. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL.
    J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
    [Abstract] [Full Text] [Related]

  • 14. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.
    Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207
    [Abstract] [Full Text] [Related]

  • 15. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T.
    Clin Cancer Res; 2004 Aug 15; 10(16):5455-63. PubMed ID: 15328184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
    Bánkfalvi A, Krassort M, Végh A, Felszeghy E, Piffkó J.
    J Oral Pathol Med; 2002 Sep 15; 31(8):450-7. PubMed ID: 12220351
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC.
    J Pathol; 2002 Feb 15; 196(2):154-62. PubMed ID: 11793366
    [Abstract] [Full Text] [Related]

  • 20. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
    Zhang WM, Lo Muzio L, Rubini C, Yan G.
    Oncol Rep; 2005 Jun 15; 13(6):1095-9. PubMed ID: 15870927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.